-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on Beta Bionics, Raises Price Target to $40

Benzinga·01/09/2026 15:14:14
Listen to the news
Lake Street analyst Frank Takkinen maintains Beta Bionics (NASDAQ:BBNX) with a Buy and raises the price target from $35 to $40.